Synthesis shows enhanced binding affinity in DNA minor groove, implying potential for anticancer drug design.
Novel guanidines are synthesized as DNA minor groove binders. Spectroscopic and DFT studies revealed that EDGs synergize with halogens to enhance binding affinity, offering promising scaffolds for anticancer drug design.
No takes yet. Share an insight, caveat, or question.
Zaman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: